A phase I/II trial of bendamustine in combination with bortezomib and pegylated liposomal doxorubicin in patients with relapsed or refractory multiple myeloma. This is a…
Hoosier Cancer Research Network, formerly known as Hoosier Oncology Group, is an independent not-for-profit organization established to explore and develop leading edge cancer treatments across the United States and internationally. Our clinical trials, developed in collaboration with academic and community oncologists, are conducted within a member network of more than 130 clinical research sites.
Hoosier Cancer Research Network’s vision and mission is to form unparalleled relationships between academic, community, pharmaceutical, and biotech partners with the goal of advancing cancer research, education, and patient advocacy.
Our highly qualified team provides comprehensive study management and support, from conception and study design through project completion and publication.